期刊文献+

盐酸阿比朵尔在大鼠体内的药代动力学 被引量:2

Pharmacokinetics of arbidol hydrochloride in rats
下载PDF
导出
摘要 目的研究盐酸阿比朵尔在大鼠体内的药代动力学。方法将健康♂Wistar系大鼠(200~220 g),随机分组,每组6只。单次灌胃给予药物,剂量分别为9、18、54 mg.kg-1,从眼眶静脉丛分时取血、处理。采用高效液相色谱-质谱联用方法测定药物在血浆中的浓度,应用DAS 2.0软件计算主要药代动力学参数。结果按9、18、54 mg.kg-13个剂量分别单次灌胃给予大鼠盐酸阿比朵尔后,药物在动物体内的Cmax分别为644.1、1002、4711μg.L-1;Tmax分别为0.35、0.28、0.18 h;AUC0-t分别为1127、1956、6790μg.h.L-1;AUC0-∞分别为1250、2224、7558μg.h.L-1;T12分别为3.2、3.6、3.3 h。结论以上数据经统计学分析,结果表明:在9~54 mg.kg-1剂量范围内,单剂量灌胃给予大鼠盐酸阿比朵尔后,药物在动物体内的动力学行为具有线性特征。 Aim To investigate the pharmacokinetic characteristics of arbidol hydrochloride in rats.Methods Wister rats were used in this experiment whose body weights ranged from 200 to 220 g.The animals were distributed to three test groups at random(6 for each group).The pharmacokinetic processes of arbidol in rats after single oral administration at different doses(9,18 and 54 mg·kg-1) were investigated.The blood samples were collected at different time points and then determined with an HPLC-MS analysis method.The main pharmacokinetic parameters were calculated by DAS 2.0 software.Results Under the oral doses of 9,18 and 54 mg·kg-1,Tmax were 0.35,0.28 and 0.18 h;Cmax were 644.1,1002 and 4711 μg·L-1;AUC0-t were 1127,1956 and 6790 μg·h·L-1;AUC0-∞ were 1250,2224 and 7558 μg·h·L-1;T1 2 were 3.2,3.6 and 3.3 h,respectively.Conclution Dose-dependent linear relationship of AUC0-t and Cmax for arbidol is found in the range of 9 to 54 mg·kg-1 after oral administration to rats.T1 2 values from the three groups show no significant difference by rank sum test.
出处 《中国药理学通报》 CAS CSCD 北大核心 2012年第12期1747-1750,共4页 Chinese Pharmacological Bulletin
基金 国家自然科学基金资助项目(No 20372047)
关键词 盐酸阿比朵尔 药代动力学 线性 高效液相色谱-质谱联用法 大鼠 灌胃 arbidol hydrochloride pharmacokinetics linear HPLC-MS rat oral administration
  • 相关文献

参考文献5

  • 1洪丽萍,陈云飞.预防和治疗儿童流感、急性病毒性呼吸道感染的化学药物——阿比朵尔[J].上海医药,2007,28(9):409-411. 被引量:3
  • 2Beliaev A L, Burtseva E I, Slepushkin A N, et al. Arbidol a new drug for prevention of influenza and acute viral respiratory infections in children [J]. Vestn Ross Akad Med Nauk, 1996, 9 (8) : 34-7.
  • 3Semenenko T A, Selkova E P, Gotvianskaia T P, et al. Characteristics of the immune ststus in specific and nonspecific prophylaxis of influenza in elderly persons [J]. Zh Mikrobiol Epidemiol Immunobiol, 2005(6):24-8.
  • 4Metz R, Muth P, Ferger M, et al. Sensitive highperformance liquid chromatographic determination of arbidol, a new antiviral compound, in human plasma [J]. J Chromatogr A, 1998, 810: 63-9.
  • 5杨昭毅,魏伟.药代动力学药效动力学结合模型研究进展[J].中国药理学通报,2005,21(8):918-922. 被引量:13

二级参考文献8

共引文献14

同被引文献36

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部